Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,330 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Myriad Genetic Laboratories, Inc. | $307.63 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $289.55 | 3 | $0 (2020) |
| Astellas Pharma US Inc | $169.56 | 3 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $106.86 | 4 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $98.74 | 7 | $0 (2021) |
| Dendreon Pharmaceuticals LLC | $46.91 | 2 | $0 (2021) |
| Telix Pharmaceuticals | $46.54 | 2 | $0 (2024) |
| Tolmar, Inc. | $44.21 | 2 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $41.77 | 2 | $0 (2024) |
| Cook Medical LLC | $30.15 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $253.09 | 11 | Myriad Genetic Laboratories, Inc. ($82.90) |
| 2023 | $246.92 | 12 | Myriad Genetic Laboratories, Inc. ($97.72) |
| 2022 | $109.60 | 6 | Myriad Genetic Laboratories, Inc. ($94.40) |
| 2021 | $173.94 | 6 | Astellas Pharma US Inc ($69.78) |
| 2020 | $134.45 | 2 | AstraZeneca Pharmaceuticals LP ($120.00) |
| 2019 | $311.82 | 7 | AstraZeneca Pharmaceuticals LP ($169.55) |
| 2018 | $41.49 | 3 | Foundation Medicine, Inc. ($15.06) |
| 2017 | $58.96 | 4 | TOLMAR Pharmaceuticals, Inc. ($58.96) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $30.67 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: ONCOLOGY | ||||||
| 09/06/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: HORMONE THERAPY | ||||||
| 08/22/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $18.97 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | IMMUNITYBIO, INC. | ANKTIVA (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: Immunotherapy | ||||||
| 03/30/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 02/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Oncology | ||||||
| 12/06/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $30.43 | General |
| Category: Oncology | ||||||
| 11/30/2023 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 08/04/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Urology | ||||||
| 06/02/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Oncology | ||||||
| 04/28/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: ONCOLOGY | ||||||
| 03/30/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: Urology | ||||||
| 03/03/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: ONCOLOGY | ||||||
| 01/12/2023 | Tolmar, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: Prostate Cancer | ||||||
| 01/06/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2022 | Myriad Genetic Laboratories, Inc. | Prolaris (Device) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: Gene Expression Analysis Oncology | ||||||
| 10/18/2022 | UroGen Pharma, Inc. | — | Food and Beverage | In-kind items and services | $15.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 61 | 101,643 | 187,116 | $12.3M | $5.5M |
| 2022 | 61 | 75,630 | 114,552 | $7.5M | $3.2M |
| 2021 | 47 | 73,124 | 110,927 | $7.8M | $3.4M |
| 2020 | 47 | 68,555 | 102,375 | $8.1M | $3.4M |
All Medicare Procedures & Services
216 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 2,633 | 41,333 | $2.8M | $1.4M | 49.1% |
| 88120 | Cell examination of urine, manual | Office | 2023 | 1,433 | 1,934 | $2.3M | $877,317 | 38.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 16,724 | 23,566 | $871,944 | $424,369 | 48.7% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 5,757 | 7,442 | $966,746 | $370,487 | 38.3% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Office | 2023 | 1,264 | 1,272 | $871,092 | $351,328 | 40.3% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 2,632 | 7,627 | $534,923 | $262,014 | 49.0% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 12,736 | 22,548 | $360,940 | $178,199 | 49.4% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 3,201 | 5,333 | $277,316 | $134,735 | 48.6% |
| 87556 | Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique | Office | 2023 | 2,589 | 3,235 | $268,485 | $131,881 | 49.1% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 5,034 | 6,687 | $247,419 | $120,401 | 48.7% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 2,637 | 3,287 | $230,073 | $112,815 | 49.0% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 2,586 | 3,230 | $226,083 | $110,854 | 49.0% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 2,582 | 3,224 | $225,663 | $110,648 | 49.0% |
| 87186 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | Office | 2023 | 6,647 | 11,257 | $191,323 | $95,369 | 49.8% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2023 | 6,800 | 11,521 | $184,278 | $91,155 | 49.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 685 | 1,542 | $213,191 | $84,122 | 39.5% |
| 87511 | Detection test for gardnerella vaginalis (bacteria), amplified probe technique | Office | 2023 | 1,561 | 1,982 | $138,723 | $68,001 | 49.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Office | 2023 | 194 | 284 | $156,444 | $62,797 | 40.1% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 1,451 | 1,733 | $121,310 | $59,478 | 49.0% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 1,439 | 1,718 | $120,260 | $58,988 | 49.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 2,667 | 3,520 | $73,920 | $36,404 | 49.2% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 3,061 | 3,480 | $59,151 | $28,811 | 48.7% |
| 87532 | Detection test by nucleic acid for herpes virus-6, amplified probe technique | Office | 2023 | 713 | 798 | $55,860 | $27,413 | 49.1% |
| 87496 | Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique | Office | 2023 | 713 | 798 | $55,860 | $27,379 | 49.0% |
| 84270 | Sex hormone binding globulin (protein) level | Office | 2023 | 886 | 1,288 | $55,384 | $27,378 | 49.4% |
About Dr. Nicholas Maruniak, MD
Dr. Nicholas Maruniak, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Oxford, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235190356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Maruniak, MD has received a total of $1,330 in payments from pharmaceutical and medical device companies, with $253.09 received in 2024. These payments were reported across 51 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,330).
As a Medicare-enrolled provider, Maruniak has provided services to 318,952 Medicare beneficiaries, totaling 514,970 services with total Medicare billing of $15.5M. Data is available for 4 years (2020–2023), covering 216 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Oxford, FL
- Active Since 03/29/2006
- Last Updated 12/16/2020
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1235190356
Products in Payments
- LYNPARZA (Drug) $203.42
- PROLARIS (Device) $180.62
- XTANDI (Drug) $143.22
- ELIGARD (Drug) $142.95
- Prolaris (Device) $127.01
- Nubeqa (Drug) $106.86
- IMFINZI (Drug) $86.13
- PROVENGE (Drug) $46.91
- ILLUCCIX (Drug) $46.54
- ANKTIVA (Drug) $28.64
- Myrbetriq (Drug) $26.34
- PLUVICTO (Drug) $25.03
- ORGOVYX (Drug) $20.94
- GEMTESA (Drug) $20.83
- Cook Medical Wire Guides (Device) $15.70
- FOUNDATIONONE (Device) $15.06
- Cook Medical Lasers (Device) $14.45
- Stendra (Drug) $12.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Oxford
Dr. Barbara Proctor, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $177.97
Dr. William Poston, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $18.21
Dr. Rickey Hicks, M.d, M.D
Anatomic Pathology & Clinical Pathology
Dr. Jared Cobb, Md, MD
Anatomic Pathology & Clinical Pathology